Good Cascade Impactor Practices - Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products - page 114

76. Product Quality Research Institute (2012) Information about PQRI as well as reports of WG
meetings can be found at: http://www.pqri.org/ . Visited 10 Jan 2012
77. Mitchell JP, Bauer R, Lyapustina S, Tougas T, Glaab V (2011) Non-impactor-based methods
for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs). AAPS
PharmSciTech 12(3):965-988
78. Mitchell JP, Dunbar C (2005) Analysis of cascade impactor mass distributions. J Aerosol Med
18(4):439-451
79. Christopher JD, Dey M, Lyapustina S, Mitchell JP, Tougas TP, Van Oort M, Strickland H,
Wyka B (2010) Generalized simplified approaches for mass median aerodynamic determina-
tion. Pharm Forum 36(3):812-823
80. Mitchell JP, Nagel MW (2000) Spacer and holding chamber testing in vitro : a critical analysis
with examples. In: Dalby RN, Byron PR, Farr SJ, Peart J (eds) Respiratory drug delivery-VII.
Serentec Press, Raleigh, NC, pp 265-274
81. Lefebvre AH (1989) Atomization and sprays. Taylor and Francis, Hemisphere Publishing
Corporation, New York, NY
82. Lewis DA (2008) New cascade impactor software. Inhalation 2(4):7-10
83. Hinds WC (1998) Properties, behavior, and measurement of airborne particles, 2nd edn.
Wiley-Interscience, New York, NY, pp 75-110